You are viewing the site in preview mode

Skip to main content

Advertisement

Open Peer Review Reports for: Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
22 May 2018 Submitted Original manuscript
6 Jul 2018 Reviewed Reviewer Report - Sophie Willemse
14 Aug 2018 Reviewed Reviewer Report - Karin Neukam
1 Nov 2018 Author responded Author comments - Anne Laurain
Resubmission - Version 2
1 Nov 2018 Submitted Manuscript version 2
13 Dec 2018 Reviewed Reviewer Report - Karin Neukam
7 Jan 2019 Reviewed Reviewer Report - Sophie Willemse
4 Feb 2019 Author responded Author comments - Anne Laurain
Resubmission - Version 3
4 Feb 2019 Submitted Manuscript version 3
16 Mar 2019 Author responded Author comments - Anne Laurain
Resubmission - Version 4
16 Mar 2019 Submitted Manuscript version 4
Publishing
19 Mar 2019 Editorially accepted
2 Apr 2019 Article published 10.1186/s12879-019-3923-5

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement